CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2500
+0.0003 (0.12%)
Feb 9, 2026, 10:16 AM EST
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $317.38 million as of February 9, 2026. Its market cap has increased by 18.16% in one year.
Market Cap
317.38M
Enterprise Value
339.66M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.25
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 317.38M, an increase of 5,631.33%. That is a compound annual growth rate of 22.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 317.38M | -10.74% |
| Dec 31, 2025 | 355.55M | 164.08% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 406.62M |
| Silence Therapeutics | 224.36M |
| Vaxart | 145.67M |
| HST Global | 139.70M |
| BioStem Technologies | 104.83M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |
| Vicapsys Life Sciences | 48.56M |